img

Global BCG and Tuberculosis Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global BCG and Tuberculosis Vaccine Market Insights, Forecast to 2034

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Global BCG and Tuberculosis Vaccine market is expected to reach to US$ 78 million in 2024, with a positive growth of %, compared with US$ 76 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, BCG and Tuberculosis Vaccine industry is evaluated to reach US$ 93 million in 2029. The CAGR will be 3.0% during 2024 to 2029.
The tuberculosis (TB) vaccination market is driven by the global efforts to combat TB and the increasing burden of the disease in high-risk populations. TB is a highly contagious bacterial infection that poses a significant public health challenge worldwide. Vaccination against TB, primarily through the Bacille Calmette-Guérin (BCG) vaccine, is essential in reducing TB incidence and severity, especially in endemic regions. The rise in TB cases and drug-resistant strains contribute to market growth as governments and healthcare organizations focus on prevention strategies. Moreover, advancements in vaccine research and development, including novel TB vaccines under investigation, have the potential to further improve TB control efforts. However, the market also faces challenges, including the variable efficacy of the BCG vaccine against different forms of TB and the need for improved vaccine coverage in high-burden areas. Additionally, addressing vaccine supply and distribution challenges and ensuring equitable access to TB vaccination can pose obstacles for comprehensive disease control. To succeed, companies must focus on research and development to offer innovative TB vaccine candidates, collaborate with global health initiatives to promote vaccination campaigns, and address the challenges to meet the increasing demand for effective TB prevention solutions.
Report Covers
This report presents an overview of global BCG and Tuberculosis Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global BCG and Tuberculosis Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine

Segment by Application


Self-Procurement
UNICEF
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ BCG and Tuberculosis Vaccine plant distribution, commercial date of BCG and Tuberculosis Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, BCG and Tuberculosis Vaccine introduction, etc. BCG and Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of BCG and Tuberculosis Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 BCG and Tuberculosis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global BCG and Tuberculosis Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global BCG and Tuberculosis Vaccine Revenue by Region
2.2.1 Global BCG and Tuberculosis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global BCG and Tuberculosis Vaccine Revenue by Region (2018-2024)
2.2.3 Global BCG and Tuberculosis Vaccine Revenue by Region (2024-2029)
2.2.4 Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global BCG and Tuberculosis Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global BCG and Tuberculosis Vaccine Sales by Region
2.4.1 Global BCG and Tuberculosis Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global BCG and Tuberculosis Vaccine Sales by Region (2018-2024)
2.4.3 Global BCG and Tuberculosis Vaccine Sales by Region (2024-2029)
2.4.4 Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global BCG and Tuberculosis Vaccine Sales by Manufacturers
3.1.1 Global BCG and Tuberculosis Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global BCG and Tuberculosis Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of BCG and Tuberculosis Vaccine in 2022
3.2 Global BCG and Tuberculosis Vaccine Revenue by Manufacturers
3.2.1 Global BCG and Tuberculosis Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global BCG and Tuberculosis Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by BCG and Tuberculosis Vaccine Revenue in 2022
3.3 Global Key Players of BCG and Tuberculosis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global BCG and Tuberculosis Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of BCG and Tuberculosis Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of BCG and Tuberculosis Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of BCG and Tuberculosis Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global BCG and Tuberculosis Vaccine Sales by Type
4.1.1 Global BCG and Tuberculosis Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global BCG and Tuberculosis Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
4.2 Global BCG and Tuberculosis Vaccine Revenue by Type
4.2.1 Global BCG and Tuberculosis Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global BCG and Tuberculosis Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global BCG and Tuberculosis Vaccine Price by Type
4.3.1 Global BCG and Tuberculosis Vaccine Price by Type (2018-2024)
4.3.2 Global BCG and Tuberculosis Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global BCG and Tuberculosis Vaccine Sales by Application
5.1.1 Global BCG and Tuberculosis Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global BCG and Tuberculosis Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
5.2 Global BCG and Tuberculosis Vaccine Revenue by Application
5.2.1 Global BCG and Tuberculosis Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global BCG and Tuberculosis Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global BCG and Tuberculosis Vaccine Price by Application
5.3.1 Global BCG and Tuberculosis Vaccine Price by Application (2018-2024)
5.3.2 Global BCG and Tuberculosis Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada BCG and Tuberculosis Vaccine Market Size by Type
6.1.1 US & Canada BCG and Tuberculosis Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada BCG and Tuberculosis Vaccine Revenue by Type (2018-2029)
6.2 US & Canada BCG and Tuberculosis Vaccine Market Size by Application
6.2.1 US & Canada BCG and Tuberculosis Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada BCG and Tuberculosis Vaccine Revenue by Application (2018-2029)
6.3 US & Canada BCG and Tuberculosis Vaccine Market Size by Country
6.3.1 US & Canada BCG and Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada BCG and Tuberculosis Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada BCG and Tuberculosis Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe BCG and Tuberculosis Vaccine Market Size by Type
7.1.1 Europe BCG and Tuberculosis Vaccine Sales by Type (2018-2029)
7.1.2 Europe BCG and Tuberculosis Vaccine Revenue by Type (2018-2029)
7.2 Europe BCG and Tuberculosis Vaccine Market Size by Application
7.2.1 Europe BCG and Tuberculosis Vaccine Sales by Application (2018-2029)
7.2.2 Europe BCG and Tuberculosis Vaccine Revenue by Application (2018-2029)
7.3 Europe BCG and Tuberculosis Vaccine Market Size by Country
7.3.1 Europe BCG and Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe BCG and Tuberculosis Vaccine Sales by Country (2018-2029)
7.3.3 Europe BCG and Tuberculosis Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China BCG and Tuberculosis Vaccine Market Size
8.1.1 China BCG and Tuberculosis Vaccine Sales (2018-2029)
8.1.2 China BCG and Tuberculosis Vaccine Revenue (2018-2029)
8.2 China BCG and Tuberculosis Vaccine Market Size by Application
8.2.1 China BCG and Tuberculosis Vaccine Sales by Application (2018-2029)
8.2.2 China BCG and Tuberculosis Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia BCG and Tuberculosis Vaccine Market Size by Type
9.1.1 Asia BCG and Tuberculosis Vaccine Sales by Type (2018-2029)
9.1.2 Asia BCG and Tuberculosis Vaccine Revenue by Type (2018-2029)
9.2 Asia BCG and Tuberculosis Vaccine Market Size by Application
9.2.1 Asia BCG and Tuberculosis Vaccine Sales by Application (2018-2029)
9.2.2 Asia BCG and Tuberculosis Vaccine Revenue by Application (2018-2029)
9.3 Asia BCG and Tuberculosis Vaccine Sales by Region
9.3.1 Asia BCG and Tuberculosis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia BCG and Tuberculosis Vaccine Revenue by Region (2018-2029)
9.3.3 Asia BCG and Tuberculosis Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Japan BCG Lab
11.2.1 Japan BCG Lab Company Information
11.2.2 Japan BCG Lab Overview
11.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Japan BCG Lab BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Japan BCG Lab Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Serum Institute of India BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 AJ Vaccines
11.4.1 AJ Vaccines Company Information
11.4.2 AJ Vaccines Overview
11.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AJ Vaccines BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AJ Vaccines Recent Developments
11.5 BioFarma
11.5.1 BioFarma Company Information
11.5.2 BioFarma Overview
11.5.3 BioFarma BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 BioFarma BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioFarma Recent Developments
11.6 GreenSignal Bio Pharma
11.6.1 GreenSignal Bio Pharma Company Information
11.6.2 GreenSignal Bio Pharma Overview
11.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GreenSignal Bio Pharma Recent Developments
11.7 China National Biotec
11.7.1 China National Biotec Company Information
11.7.2 China National Biotec Overview
11.7.3 China National Biotec BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 China National Biotec BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Recent Developments
11.8 Biomed Lublin
11.8.1 Biomed Lublin Company Information
11.8.2 Biomed Lublin Overview
11.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biomed Lublin BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomed Lublin Recent Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Overview
11.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taj Pharmaceuticals Recent Developments
11.10 Ataulpho de Paiva
11.10.1 Ataulpho de Paiva Company Information
11.10.2 Ataulpho de Paiva Overview
11.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ataulpho de Paiva Recent Developments
11.11 IVAC-Institute of Vaccines and Medical Biologicals
11.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Information
11.11.2 IVAC-Institute of Vaccines and Medical Biologicals Overview
11.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
11.12 Queen Saovabha Mem. Inst
11.12.1 Queen Saovabha Mem. Inst Company Information
11.12.2 Queen Saovabha Mem. Inst Overview
11.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Queen Saovabha Mem. Inst Recent Developments
11.13 Microgen
11.13.1 Microgen Company Information
11.13.2 Microgen Overview
11.13.3 Microgen BCG and Tuberculosis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Microgen BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Microgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 BCG and Tuberculosis Vaccine Industry Chain Analysis
12.2 BCG and Tuberculosis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 BCG and Tuberculosis Vaccine Production Mode & Process
12.4 BCG and Tuberculosis Vaccine Sales and Marketing
12.4.1 BCG and Tuberculosis Vaccine Sales Channels
12.4.2 BCG and Tuberculosis Vaccine Distributors
12.5 BCG and Tuberculosis Vaccine Customers
13 Market Dynamics
13.1 BCG and Tuberculosis Vaccine Industry Trends
13.2 BCG and Tuberculosis Vaccine Market Drivers
13.3 BCG and Tuberculosis Vaccine Market Challenges
13.4 BCG and Tuberculosis Vaccine Market Restraints
14 Key Findings in The Global BCG and Tuberculosis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Immune Vaccine
Table 3. Major Manufacturers of Therapy Vaccine
Table 4. Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global BCG and Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global BCG and Tuberculosis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global BCG and Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global BCG and Tuberculosis Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global BCG and Tuberculosis Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global BCG and Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global BCG and Tuberculosis Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global BCG and Tuberculosis Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global BCG and Tuberculosis Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global BCG and Tuberculosis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of BCG and Tuberculosis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. BCG and Tuberculosis Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global BCG and Tuberculosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global BCG and Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG and Tuberculosis Vaccine as of 2022)
Table 23. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of BCG and Tuberculosis Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global BCG and Tuberculosis Vaccine Sales Share by Type (2018-2024)
Table 30. Global BCG and Tuberculosis Vaccine Sales Share by Type (2024-2029)
Table 31. Global BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global BCG and Tuberculosis Vaccine Revenue Share by Type (2018-2024)
Table 34. Global BCG and Tuberculosis Vaccine Revenue Share by Type (2024-2029)
Table 35. BCG and Tuberculosis Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global BCG and Tuberculosis Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global BCG and Tuberculosis Vaccine Sales Share by Application (2018-2024)
Table 40. Global BCG and Tuberculosis Vaccine Sales Share by Application (2024-2029)
Table 41. Global BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global BCG and Tuberculosis Vaccine Revenue Share by Application (2018-2024)
Table 44. Global BCG and Tuberculosis Vaccine Revenue Share by Application (2024-2029)
Table 45. BCG and Tuberculosis Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global BCG and Tuberculosis Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada BCG and Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada BCG and Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada BCG and Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada BCG and Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada BCG and Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe BCG and Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe BCG and Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe BCG and Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe BCG and Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe BCG and Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia BCG and Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia BCG and Tuberculosis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia BCG and Tuberculosis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia BCG and Tuberculosis Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia BCG and Tuberculosis Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Merck BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Japan BCG Lab Company Information
Table 113. Japan BCG Lab Description and Major Businesses
Table 114. Japan BCG Lab BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Japan BCG Lab BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Japan BCG Lab Recent Developments
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Description and Major Businesses
Table 119. Serum Institute of India BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Serum Institute of India BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Serum Institute of India Recent Developments
Table 122. AJ Vaccines Company Information
Table 123. AJ Vaccines Description and Major Businesses
Table 124. AJ Vaccines BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. AJ Vaccines BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AJ Vaccines Recent Developments
Table 127. BioFarma Company Information
Table 128. BioFarma Description and Major Businesses
Table 129. BioFarma BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. BioFarma BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. BioFarma Recent Developments
Table 132. GreenSignal Bio Pharma Company Information
Table 133. GreenSignal Bio Pharma Description and Major Businesses
Table 134. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GreenSignal Bio Pharma Recent Developments
Table 137. China National Biotec Company Information
Table 138. China National Biotec Description and Major Businesses
Table 139. China National Biotec BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. China National Biotec BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. China National Biotec Recent Developments
Table 142. Biomed Lublin Company Information
Table 143. Biomed Lublin Description and Major Businesses
Table 144. Biomed Lublin BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biomed Lublin BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biomed Lublin Recent Developments
Table 147. Taj Pharmaceuticals Company Information
Table 148. Taj Pharmaceuticals Description and Major Businesses
Table 149. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Taj Pharmaceuticals BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Taj Pharmaceuticals Recent Developments
Table 152. Ataulpho de Paiva Company Information
Table 153. Ataulpho de Paiva Description and Major Businesses
Table 154. Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Ataulpho de Paiva BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Ataulpho de Paiva Recent Developments
Table 157. IVAC-Institute of Vaccines and Medical Biologicals Company Information
Table 158. IVAC-Institute of Vaccines and Medical Biologicals Description and Major Businesses
Table 159. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. IVAC-Institute of Vaccines and Medical Biologicals Recent Developments
Table 162. Queen Saovabha Mem. Inst Company Information
Table 163. Queen Saovabha Mem. Inst Description and Major Businesses
Table 164. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Queen Saovabha Mem. Inst Recent Developments
Table 167. Microgen Company Information
Table 168. Microgen Description and Major Businesses
Table 169. Microgen BCG and Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Microgen BCG and Tuberculosis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Microgen Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. BCG and Tuberculosis Vaccine Distributors List
Table 175. BCG and Tuberculosis Vaccine Customers List
Table 176. BCG and Tuberculosis Vaccine Market Trends
Table 177. BCG and Tuberculosis Vaccine Market Drivers
Table 178. BCG and Tuberculosis Vaccine Market Challenges
Table 179. BCG and Tuberculosis Vaccine Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. BCG and Tuberculosis Vaccine Product Picture
Figure 2. Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global BCG and Tuberculosis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global BCG and Tuberculosis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global BCG and Tuberculosis Vaccine Market Share by Application in 2022 & 2029
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Others
Figure 11. BCG and Tuberculosis Vaccine Report Years Considered
Figure 12. Global BCG and Tuberculosis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global BCG and Tuberculosis Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global BCG and Tuberculosis Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global BCG and Tuberculosis Vaccine Sales 2018-2029 ((K Units)
Figure 17. Global BCG and Tuberculosis Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada BCG and Tuberculosis Vaccine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada BCG and Tuberculosis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe BCG and Tuberculosis Vaccine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe BCG and Tuberculosis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China BCG and Tuberculosis Vaccine Sales YoY (2018-2029) & (K Units)
Figure 23. China BCG and Tuberculosis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) BCG and Tuberculosis Vaccine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) BCG and Tuberculosis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The BCG and Tuberculosis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of BCG and Tuberculosis Vaccine in the World: Market Share by BCG and Tuberculosis Vaccine Revenue in 2022
Figure 30. Global BCG and Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada BCG and Tuberculosis Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada BCG and Tuberculosis Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe BCG and Tuberculosis Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe BCG and Tuberculosis Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia BCG and Tuberculosis Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia BCG and Tuberculosis Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America BCG and Tuberculosis Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries BCG and Tuberculosis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. BCG and Tuberculosis Vaccine Value Chain
Figure 81. BCG and Tuberculosis Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries